Medical News

RSS

Meda AB's net sales for first-quarter 2010 decrease 14% to SEK 2,943M

After a strong Q4 in 2009, net sales decreased 14% in Q1 to SEK 2,943 million (3,437). Mainly currency effects but also increased competition for Astelin and Optivar reduced sales by more than SEK 400 million, compared with the same period last year.

5 May 2010

FDA requested to publish data supporting assertion on HPV types 6, 11 causing vulvar, vaginal cancers

A Connecticut cancer pathologist/physician/scientist with extensive experience in the field for the past half century has formally challenged the FDA to back claims on its website that human papillomavirus (HPV) genotypes 6 and 11 cause vulvar and vaginal cancers in women.

5 May 2010

Special issue of Progress in Cardiovascular Diseases

High altitude medicine is a "natural research laboratory" for the study of cardiovascular physiology and pathophysiology. As such, it can shed light on conditions and diseases that mimic the low oxygen content of the atmosphere at the top of mountains.

5 May 2010

Archivel Farma to start phase II clinical trials of RUTI vaccine for Latent Tuberculosis

Archivel Farma, S.L. has announced that its breakthrough treatment for tuberculosis (TB) will shortly start phase II clinical trials. The treatment uses the company's unique combination of its novel therapeutic vaccine called RUTI® in conjunction with an antibiotic. This cuts treatment time from nine months to one month, which reduces side effects and healthcare costs, by preventing re-infection during the eradication process. The company expects commercial availability in 2015.

5 May 2010

Castle Montessori Schools announce donation of $13,000 to JDRF Walk to Cure Diabetes

Castle Montessori Schools, a leader in Montessori education, believes it is their responsibility to contribute to the health and wellness of the community through active participation in local events and donations to charitable organizations. The schools proudly announce a donation of $13,000 to the Juvenile Diabetes Research Foundation "Walk to Cure Diabetes."

5 May 2010

HbA1c can be deceptive in African American children with diabetes: Study

Researchers at LSU Health Sciences Center New Orleans and Children's Hospital of New Orleans have found that there is a major difference in the hemoglobin A1c response to blood glucose between African-American and Caucasian children with diabetes. HbA1c is the main test used to monitor diabetes and guide treatment decisions.

5 May 2010

Palatin Technologies granted patent relating to small molecule compounds that bind to melanocortin receptors

Palatin Technologies, Inc. announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 7,709,484, titled "Substituted Melanocortin Receptor-Specific Piperazine Compounds," today. The claims in the issued patent relate to small molecule compounds which bind to melanocortin receptors.

5 May 2010

Three Hamilton scientists receive cancer research grants from Canadian Cancer Society

Three Hamilton scientists are receiving new funding from the Canadian Cancer Society for their work in innovative cancer research.

5 May 2010

FDA's call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF

The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years. On March 9, 2010, an FDA Advisory Committee recommended approval of the drug by the FDA.

5 May 2010

BioDiscovery signs OEM Agreement with Exiqon

BioDiscovery, Inc., a leader in integrated software solutions for microarray-based research, and Exiqon A/S, a leader in microRNA analysis products and services, announced today an OEM Agreement incorporating BioDiscovery's array analysis and visualization software with Exiqon's arrays.

5 May 2010

Abbott announces opening of Asia-Pacific Nutrition R&D Center

Abbott, the global health care company, today announced the opening of the Abbott Asia-Pacific Nutrition Research & Development Center at Singapore's Biopolis Research Park. The center is Abbott's largest nutrition R&D facility outside of the U.S., and Singapore's first nutrition R&D site creating science-based nutritional products for infants, children and adults.

5 May 2010

Protein PEA-15 stops T-cell proliferation

New research has identified that a key protein called PEA-15 stops T-cell proliferation by blocking the cell's ability to reproduce. The control of T-cell proliferation is essential in preventing certain blood cancers and autoimmune diseases, as well as the orchestration of the immune response to infection. Findings of the study are reported in a recent online issue of The FASEB Journal, a publication of The Federation of American Societies for Experimental Biology.

5 May 2010

New treatments for intestinal failure, other intestinal absorption disorders

New treatments for intestinal failure and other intestinal absorption disorders are a step closer to the patients who need them after a discovery in Kelly Tappenden's University of Illinois laboratory.

5 May 2010

Researchers analyze role of gender in treatment and outcome of patients with MMD

Moyamoya disease is an uncommon, progressive cerebrovascular disease in which the main arteries feeding the brain (the intracranial internal carotid arteries/ICA and Circle of Willis) are narrowed or occluded on both sides, reducing blood flow to the brain. This causes transient episodes of reversible stroke with loss of neurologic function in the form of weakness of a limb, sensory disturbances, epileptic seizures or headaches.

5 May 2010

Americans and their babies are gaining more body fat: Study

A new study has found for the first time that as Americans are gaining more body fat, so are their babies. The research, which reviewed data from more than 74,000 births, found that a key measure of body fat composition in newborns increased significantly over a 15-year period, mirroring similar increases among pregnant mothers. The findings were presented Sunday by researchers from Children's Mercy Hospitals and Clinics at the Pediatric Academic Societies annual meeting.

5 May 2010

New pathology test may help doctors distinguish between two overlapping esophageal disorders: Study

A pathology test may help doctors distinguish between two separate but overlapping esophageal disorders that require different courses of treatment, according to a study by researchers at the University of North Carolina at Chapel Hill.

5 May 2010

UK GTAC, MHRA approve Scancell's Phase I clinical trial of SCIB1 DNA ImmunoBody vaccine

Scancell Holdings Plc,, the developer of therapeutic cancer vaccines, today announced at BIO2010 in Chicago that its proposal to conduct a Phase I clinical trial on SCIB1, its DNA ImmunoBody® vaccine being developed for the treatment of melanoma, has been approved in the UK by the Gene Therapy Advisory Committee and by the Medicines and Healthcare products Regulatory Agency Medicines Division.

5 May 2010

Study investigates pilot VBBD program to improve adherence to diabetes medications

A recent study led by MedImpact Healthcare Systems, Inc. investigated a pilot Value-Based Benefit Design program to improve adherence to diabetes medications. The study found that a VBBD program that reduced copayments for diabetes medications by 36 percent reduced the number of non-adherent patients by 30 percent.

5 May 2010

HEALTHGRAIN Forum to develop European definition of whole grain

Cereal grain kernels consist of three main parts: endosperm, bran and germ. In Europe and worldwide most cereal products, like white bread, are based on kernels or flour after removal of bran and germ, the two parts containing most of the dietary fibre and other bioactive components. In the past decade consumers have been rediscovering whole grain based products. As a result consumption of whole grain products is growing world wide and in Europe also in countries where whole grain products were hardly known.

5 May 2010

Enzyme technology developed to improve quality, safety and nutritional attributes of oat based foods

Oats is a highly nutritious cereal, which can be tolerated by large number of celiac patients. A range of commercial oat flours as well as specific oat flours produced from single varieties have been evaluated for their suitability for bread-baking. Enzyme technology, bioprocessing as well as high-pressure processing technology have been successfully applied to improve the quality, safety and nutritional attributes of oat based foods.

5 May 2010

Medical News

Meda AB's net sales for first-quarter 2010 decrease 14% to SEK 2,943M

FDA requested to publish data supporting assertion on HPV types 6, 11 causing vulvar, vaginal cancers

Special issue of Progress in Cardiovascular Diseases

Archivel Farma to start phase II clinical trials of RUTI vaccine for Latent Tuberculosis

Castle Montessori Schools announce donation of $13,000 to JDRF Walk to Cure Diabetes

HbA1c can be deceptive in African American children with diabetes: Study

Palatin Technologies granted patent relating to small molecule compounds that bind to melanocortin receptors

Three Hamilton scientists receive cancer research grants from Canadian Cancer Society

FDA's call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF

BioDiscovery signs OEM Agreement with Exiqon

Abbott announces opening of Asia-Pacific Nutrition R&D Center

Protein PEA-15 stops T-cell proliferation

New treatments for intestinal failure, other intestinal absorption disorders

Researchers analyze role of gender in treatment and outcome of patients with MMD

Americans and their babies are gaining more body fat: Study

New pathology test may help doctors distinguish between two overlapping esophageal disorders: Study

UK GTAC, MHRA approve Scancell's Phase I clinical trial of SCIB1 DNA ImmunoBody vaccine

Study investigates pilot VBBD program to improve adherence to diabetes medications

HEALTHGRAIN Forum to develop European definition of whole grain

Enzyme technology developed to improve quality, safety and nutritional attributes of oat based foods

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News